Envestnet Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-21,195
| Closed | -$1.53M | – | 3622 |
|
|
2020
Q4 | $1.53M | Sell |
21,195
-1,269
| -6% | -$66.4K | ﹤0.01% | 1933 |
|
|
2020
Q3 | $1.02M | Sell |
22,464
-15,918
| -41% | -$665K | ﹤0.01% | 1996 |
|
|
2020
Q2 | $1.73M | Sell |
38,382
-2,166
| -5% | -$97.1K | ﹤0.01% | 1658 |
|
|
2020
Q1 | $1.56M | Buy |
40,548
+66
| +0.2% | +$3.04K | ﹤0.01% | 1554 |
|
|
2019
Q4 | $1.87M | Buy |
40,482
+7,231
| +22% | +$313K | ﹤0.01% | 1649 |
|
|
2019
Q3 | $1.35M | Buy |
33,251
+1,782
| +6% | +$76.9K | ﹤0.01% | 1767 |
|
|
2019
Q2 | $1.51M | Buy |
31,469
+8,725
| +38% | +$459K | ﹤0.01% | 1711 |
|
|
2019
Q1 | $1.42M | Buy |
22,744
+5,103
| +29% | +$351K | ﹤0.01% | 1666 |
|
|
2018
Q4 | $1.05M | Buy |
+17,641
| New | +$1.06M | ﹤0.01% | 1716 |
|
|
2018
Q3 | – | Sell |
-4,824
| Closed | -$217K | – | 3141 |
|
|
2018
Q2 | $217K | Sell |
4,824
-888
| -16% | -$35.4K | ﹤0.01% | 1630 |
|
|
2018
Q1 | $179K | Sell |
5,712
-14,150
| -71% | -$465K | ﹤0.01% | 1640 |
|
|
2017
Q4 | $594K | Buy |
19,862
+221
| +1% | +$6.4K | ﹤0.01% | 1402 |
|
|
2017
Q3 | $648K | Buy |
19,641
+1,322
| +7% | +$45.8K | ﹤0.01% | 1344 |
|
|
2017
Q2 | $614K | Buy |
18,319
+15,251
| +497% | +$455K | ﹤0.01% | 1397 |
|
|
2017
Q1 | $89K | Buy |
+3,068
| New | +$76K | ﹤0.01% | 2226 |
|
Other funds holding BEAT
Envestnet Asset Management's BEAT Position: Q1 2021 in Review
Envestnet Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 21,195 shares — an estimated $1.53M sold.
Envestnet Asset Management first reported a position in BEAT in Q1 2017 and held it in 15 quarters. The position peaked at $1.87M in Q4 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Envestnet Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Envestnet Asset Management sold 21,195 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.53M.
- Envestnet Asset Management first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 15 quarters.
- Envestnet Asset Management's BioTelemetry, Inc. position peaked at $1.87M in Q4 2019.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Envestnet Asset Management's 13F filing for Q1 2021, filed 4 May 2021.